{"doi":"10.1001/archinte.166.2.155","title":"Medication-Attributed Adverse Effects in Placebo Groups","abstract":null,"journal":"Archives of Internal Medicine","year":2006,"id":30573,"datarank":7.457920945591624,"base_score":5.111987788356544,"endowment":5.111987788356544,"self_citation_contribution":0.7667981682534817,"citation_network_contribution":6.691122777338142,"self_endowment_contribution":0.7667981682534817,"citer_contribution":6.691122777338142,"corpus_percentile":null,"corpus_rank":null,"citation_count":165,"citer_count":136,"citers_with_citation_signal":106,"citers_with_endowment":106,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":165828,"name":"Jerry Avorn","orcid":null,"position":1,"is_corresponding":false},{"id":165830,"name":"Arthur J. Barsky","orcid":null,"position":2,"is_corresponding":false},{"id":165826,"name":"Winfried Rief","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.111987788356544,"endowment":5.111987788356544,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"16432082","pmcid":null,"openalex_id":"https://openalex.org/W1977915442","authors":[],"funders":[],"total_grants":0,"fwci":2.9528,"citation_percentile":0.90654281,"influential_citations":4,"citation_trend":[{"year":2012,"count":11},{"year":2013,"count":8},{"year":2014,"count":22},{"year":2015,"count":9},{"year":2016,"count":11},{"year":2017,"count":7},{"year":2018,"count":8},{"year":2019,"count":14},{"year":2020,"count":7},{"year":2021,"count":11},{"year":2022,"count":9},{"year":2023,"count":6},{"year":2024,"count":6},{"year":2025,"count":5},{"year":2026,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://doi.org/10.1001/archinte.166.2.155","host_type":"CLOSED"},{"url":"http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/409660","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/16432082","host_type":"repository"}],"fields_of_study":["Pain Management and Placebo Effect","Pharmacovigilance and Adverse Drug Reactions","Clinical Reasoning and Diagnostic Skills","Medicine","Adverse Drug Reaction Reporting Systems","Anticholesteremic Agents","Female","Humans","Hypercholesterolemia","Male","Placebos","Randomized Controlled Trials as Topic","Risk Assessment","Sensitivity and Specificity"],"mesh_terms":["Anticholesteremic Agents","Female","Humans","Hypercholesterolemia","Male","Placebos","Sensitivity and Specificity","Randomized Controlled Trials as Topic","Adverse Drug Reaction Reporting Systems","Risk Assessment"],"keywords":["Adverse effect","Placebo","Medicine","Discontinuation","Population","Internal medicine","Clinical trial","Statin","Alternative medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"No poverty"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T03:41:19.756584Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}